Prelude Capital Management, LLC Imara Inc. Transaction History

Prelude Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.73 - $5.2 $228,059 - $317,938	61,142 New	61,142 $250,000
Q2 2022 Aug 15, 2022	SELL	$0.99 - $1.87 $19,349 - $36,549	-19,545 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.15 - $2.41 $806 - $1,689	701 Added 3.72%	19,545 $37,000
Q4 2021 Feb 14, 2022	BUY	$2.25 - $4.05 $42,399 - $76,318	18,844 New	18,844 $42,000
Q2 2020 Aug 14, 2020	SELL	$15.6 - $54.87 $29,702 - $104,472	-1,904 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$15.0 - $16.6 $28,560 - $31,606	1,904 New	1,904 $31,000

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.